1. Home
  2. News & Publications
  3. Publications

How to access multiple datasets

Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

CTD²
BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells
Leukemia.
Read More >
CTD²
Systematic Interrogation of Tumor Cell Resistance to Chimeric Antigen Receptor T-cell Therapy in Pancreatic Cancer
Cancer Res.
Read More >
CTD²
OncoLoop: A Network-Based Precision Cancer Medicine Framework
Cancer Discov.
Read More >
CTD²
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer
Nat Cancer.
Read More >
CTD²
Secondary fusion proteins as a mechanism of BCR::ABL1 kinase-independent resistance in chronic myeloid leukaemia
Br J Haematol.
Read More >
CTD²
Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma
Cells.
Read More >
CTD²
Colorectal Cancer Metastases in the Liver Establish Immunosuppressive Spatial Networking between Tumor-Associated SPP1+ Macrophages and Fibroblasts
Clin Cancer Res.
Read More >
CTD²
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
Cancer Cell.
Read More >
CTD²
Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
Med.
Read More >
CTD²
Cellular barcoding to decipher clonal dynamics in disease
Science.
Read More >

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

Last Updated:

Content on this page maintained by the Office of Cancer Genomics